Back to Awarded Treatment Trials


Awarded Trial: 02T-123

Grant ID

02T-123

Illness

Bipolar and Unipolar Depression

Primary Drug/Intervention

Ropinirole

Primary Dosage

2 mg b.i.d.

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Grunhaus

Sample Size

60

Duration of Study Period for Each Subject

7 weeks

Outcome Measurements

HAM-D

Results

Thirty-two patients completed the study. There was no beneficial effect of ropinirole over placebo.

Publication

N/A

Link

N/A

PI Name

Leon Grunhaus

Degree

MD

Center

Sheba Medical Center

Institution

The Chaim Sheba Medical Center, Medical Research Dev.

Address

Psychiatry Department C

City or Town

Tel Hashomer

State or Province

N/A

Zip or Postal Code

52621

Country

Israel

Email Address

kfrgrunhaus@matat.health.gov.il